Image of Jennifer J. Furin

Jennifer J. Furin, M.D., Ph.D.

Jennifer Furin, MD, PhD, is an infectious diseases clinician and a medical anthropologist who focuses on global health. She received her PhD in Medical Anthropology from the University of California at Los Angeles in 1995 and her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women’s Hospital in 2002 and her fellowship in infectious diseases at University Hospitals Case Medical Center (Cleveland) in 2004. Dr. Furin is engaged in clinical and program work and operational research to support the treatment of multidrug-resistant tuberculosis and HIV. She has been fighting drug-resistant TB since 1995 when she began working in Lima, Peru with Partners In Health. She has significant global experience and has done work in Haiti, Peru, Russia, Lesotho, South Africa, Georgia, Bangladesh, Swaziland, and Tajikistan. She is also a member of the Tuberculosis Transformation Science Committee of the AIDS Clinical Trials Group. She serves as a high-level consultant for a number of National TB Programs, WHO, USAID, and Médecins Sans Frontières

Affiliations:

Dr. Furin is also an adjunct assistant professor in the Department of Anthropology at Case Western Reserve University

Dr. Furin is the director of Clinical Capacity Building for the Sentinel Project on Pediatric Drug-Resistant Tuberculosis

Dr. Furin is participating in teaching and research in the Department's Sentinel Project on Pediatric Drug-Resistant Tuberculosis.

Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis.
Authors: Authors: Shin SS, Hyson AM, Castañeda C, Sánchez E, Alcántara F, Mitnick CD, Fawzi MC, Bayona J, Farmer PE, Kim JY, Furin JJ.
Int J Tuberc Lung Dis
View full abstract on Pubmed
The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB).
Authors: Authors: Palacios E, Guerra D, Llaro K, Chalco K, Sapag R, Furin J.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.
Authors: Authors: Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcántara F, Sánchez E, Sarria M, Becerra M, Fawzi MC, Kapiga S, Neuberg D, Maguire JH, Kim JY, Farmer P.
N Engl J Med
View full abstract on Pubmed
Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis.
Authors: Authors: Furin JJ, Mitnick CD, Shin SS, Bayona J, Becerra MC, Singler JM, Alcantara F, Castañieda C, Sanchez E, Acha J, Farmer PE, Kim JY.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Effect of administering short-course, standardized regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains.
Authors: Authors: Furin JJ, Becerra MC, Shin SS, Kim JY, Bayona J, Farmer PE.
Eur J Clin Microbiol Infect Dis
View full abstract on Pubmed
Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Authors: Authors: Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Authors: Authors: Furin, J., Walton, D., Farmer, P
The ever-changing face of AIDS: Implications for patient care